Literature DB >> 28056979

Malaria epidemiology in central Myanmar: identification of a multi-species asymptomatic reservoir of infection.

Isaac Ghinai1, Jackie Cook2, Teddy Tun Win Hla3, Hein Myat Thu Htet1, Tom Hall2, Inke Nd Lubis4, Rosanna Ghinai5, Therese Hesketh3, Ye Naung6, Mya Mya Lwin6, Tint Swe Latt6, David L Heymann7, Colin J Sutherland4, Chris Drakeley2, Nigel Field8.   

Abstract

BACKGROUND: The spread of artemisinin-resistant Plasmodium falciparum is a global health concern. Myanmar stands at the frontier of artemisinin-resistant P. falciparum. Myanmar also has the highest reported malaria burden in Southeast Asia; it is integral in the World Health Organization's plan to eliminate malaria in Southeast Asia, yet few epidemiological data exist for the general population in Myanmar.
METHODS: This cross-sectional, probability household survey was conducted in Phyu township, Bago Region (central Myanmar), during the wet season of 2013. Interviewers collected clinical and behavioural data, recorded tympanic temperature and obtained dried blood spots for malaria PCR and serology. Plasmodium falciparum positive samples were tested for genetic mutations in the K13 region that may confer artemisinin resistance. Estimated type-specific malaria PCR prevalence and seroprevalence were calculated, with regression analysis to identify risk factors for seropositivity to P. falciparum. Data were weighted to account for unequal selection probabilities.
RESULTS: 1638 participants were sampled (500 households). Weighted PCR prevalence was low (n = 41, 2.5%) and most cases were afebrile (93%). Plasmodium falciparum was the most common species (n = 19. 1.1%) and five (26%) P. falciparum samples harboured K13 mutations. Plasmodium knowlesi was detected in 1.0% (n = 16) and Plasmodium vivax was detected in 0.4% (n = 7). Seroprevalence was 9.4% for P. falciparum and 3.1% for P. vivax. Seroconversion to P. falciparum was 0.003/year in the whole population, but 16-fold higher in men over 23 years old (LR test p = 0.016). DISCUSSION: This is the first population-based seroprevalence study from central Myanmar. Low overall prevalence was discovered. However, these data suggest endemic transmission continues, probably associated with behavioural risk factors amongst working-age men. Genetic mutations associated with P. falciparum artemisinin resistance, the presence of P. knowlesi and discrete demographic risk groups present opportunities and challenges for malaria control. Responses targeted to working-age men, capable of detecting sub-clinical infections, and considering all species will facilitate malaria elimination in this setting.

Entities:  

Keywords:  Artemisinin; Elimination; Malaria; Myanmar; Prevalence; Resistance; Risk factors; Serology; Transmission

Mesh:

Year:  2017        PMID: 28056979      PMCID: PMC5217255          DOI: 10.1186/s12936-016-1651-5

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


Background

The last decade has seen global progress in malaria control [1, 2]. This is threatened by the emergence of Plasmodium falciparum resistant to artemisinin, the world’s front-line anti-malarial [3]. So far, P. falciparum with reduced susceptibility to artemisinin has been described in Cambodia, Thailand, Vietnam, Laos and Myanmar [4-7]. The World Health Organization (WHO) recently set its sights on malaria elimination in Southeast Asia in order to contain this threat [2]. The emergence of the zoonotic primate malaria Plasmodium knowlesi as a parasite of significant public health importance in Malaysian Borneo complicates elimination [8, 9]; the distribution and prevalence of this species in other countries in the region remains uncertain. Myanmar is reported to account for the vast majority of malaria cases and deaths within Southeast Asia [10]. Better understanding the epidemiology of malaria here would likely contribute to successful elimination. Malaria distribution in Myanmar is heterogeneous; forests are a major environmental factor driving patterns of disease [11, 12] and international and internal migration are also risk factors [13, 14]. Whilst transmission is relatively well documented in border areas [13], few data exist from central Myanmar and the burden and drivers of infection in this area remain poorly understood. Light microscopy and rapid diagnostic tests (RDTs) underestimate the prevalence of infection with Plasmodium spp, particularly in low-endemic settings [15]. Polymerase chain reaction (PCR) is more sensitive in detecting current infection and allows further testing such as for drug resistance-associated mutations [16]. Serological methods have been shown to reliably estimate malaria transmission and can identify risk factors with achievable sample sizes in low prevalence areas [17]. Prevalence of antibodies to specific malaria antigens, which indicate malaria exposure, can be used to calculate the seroconversion rate (SCR, equivalent to the force of infection) [18]. Changes in SCR over time are of particular utility in monitoring the success of public health campaigns. This study combined highly sensitive PCR testing and serological evidence of transmission intensity in a household survey in central Myanmar with collection of detailed epidemiological data to investigate the prevalence of, and risk factors for, malaria exposure.

Methods

Study site and population

Phyu is the largest township in Eastern Bago Region. Phyu is located on the main highway between Yangon (largest city) and Nay Pyi Taw (capital). It is 100 km west of the border with Thailand, and lies on a plain (highest altitude = 60 m) between forest-covered mountains (Fig. 1). The forests attract migrant labour for logging, charcoal production and agro-forestry [14]. Phyu was selected for this study due to its relatively large size and location on busy transport routes near forests. The population is approximately 250,000, of whom 89% live in semi-urban or rural areas, with 11% in Phyu town.
Fig. 1

Study site with GPS points (circles) demarcating each village cluster

Study site with GPS points (circles) demarcating each village cluster Medical services vary from a 50-bed township hospital to sub-rural health centers with no inpatient facilities. The latter cover 5–15 villages each with a midwife who provides basic services including malaria prevention. The township malaria inspector and local midwives accompanied the team for this study. The monsoon begins in May and ends in October; precipitation is heaviest in August (approximately 450 mm/month). Peaks in malaria transmission follow the rains by 1–2 months. This study was conducted in August and September 2013.

Field procedures

Sample size calculation

A required sample size of 1174 was calculated, assuming a malaria prevalence of 1 per 1000, with 95% confidence with 80% power; sampling 0.1% of the population, with a presumed design effect of 2 and a non-response rate of 15%. Since the average household size in Myanmar is 4.7, 30 clusters of 20 houses (~75 participants) were chosen (n = 1500).

Sampling technique

This cross-sectional study used a multistage cluster random sample design. Administrative wards were the primary sampling unit, with villages and houses as the secondary and tertiary sampling units. 26 of 61 wards were included (population = 152,651, 60.2% of the total). The remaining wards (population = 101,078, 39.8%) were defined as inaccessible by vehicle by the local government, necessitating exclusion. The included wards were weighted according to population size and randomly selected. From each selected ward, villages were selected at random with no population weighting. If a ward was selected more than once, more than one village was selected. Each selected village represented one cluster. A map was drawn by village leaders and houses were selected by systematic interval sampling and mapped using a Global Positioning System. Houses with no response were not revisited, the house with the closest street entrance was sampled in its place.

Questionnaires

Questionnaires were adapted from publicly available malaria indicator survey toolkits [19]. Pre-tested questionnaires were administered by pairs of community healthcare workers trained for this study. Households were defined as the group of people who had slept under the same roof the previous night and who shared a common entrance to the street. Household questionnaires recorded household structure, assets and demographic information for every household member, including those absent. Individual questionnaires recorded self-reported forest exposure, malaria symptoms and malaria prevention practices. Participants were categorized as having exposure to forest if their occupation involved forest-related work (forestry, farming, labouring) or if they reported visiting the forest within the previous 6 months. Households were classified as having universal coverage of bed nets if they reported having at least 1 net per 2 people. Socio-economic status (SES) was calculated using principal components analysis including household structure and assets. The derived score was divided into tertiles.

Clinical samples

Tympanic temperature was measured for all participants. Febrile participants (≥37.5 °C) were tested using RDT (SD Bioline Malaria Ag Pf/Pan) and referred for treatment. Capillary blood samples were spotted directly onto Whatman 3MM filter paper for all participants over 6 months old regardless of tympanic temperature. Blood spots were air-dried, sealed with silica gel and sent to the London School for Hygiene and Tropical Medicine for storage at −20 °C before analysis.

Ethical approval

The study received approval from the Research Ethics Committee of University College London, the Myanmar Ministry of Health and Department of Medical Research, Lower Myanmar. Local and regional authorities were informed. Informed consent was obtained from all adults and from guardians of children aged under 15. For those aged between 15 and 18, informed consent from both parent and child was obtained.

Laboratory procedures

Serological analysis

Recombinant proteins: Plasmodium falciparum and Plasmodium vivax antigens MSP-119 were expressed in Escherichia coli as glutathione S-transferase-fusion proteins [20] (Pv provided by A. Holder). PfAMA1_3D7 and PvAMA1_Sal1 were expressed as His-tagged proteins [21, 22]. Detection of anti-malarial antibodies by ELISA: IgG antibodies to each recombinant protein were assessed by ELISA as previously described [23]. Briefly, recombinant antigens were coated overnight at 4 °C at the following concentrations: PfAMA-1 at 0.5 μg/ml, PfMSP-119 at 0.18 μg/ml, PvAMA-1 at 1 μg/ml and PvMSP-119 at 1.8 μg/ml. Plates were washed using PBS plus 0.05% Tween 20 (PBS/T) and blocked with 1% skimmed milk powder in PBS/T. Samples and positive control sera (a pool of hyperimmune serum collected from a malaria endemic area) were tested in duplicate at 1/1000 and 1/2000 dilutions against MSP and AMA, respectively. After washing, horseradish peroxidase-conjugated polyclonal rabbit anti-human IgG (Dako, Glostrup, Denmark) diluted at 1:5000 in PBS/T was added to all wells. All plates were developed using OPD substrate (OPD, sigma fast) and reactions were stopped with 2 M H2SO4. Plates were read at 492 nm and optical density (OD) values were recorded. Seropositivity was determined using a finite mixture model to define a cut-off value as previously described [18].

PCR analysis

Parasite DNA from blood spots was extracted using the Chelex method [24]. PCR amplifications targeting the 18S rRNA gene was performed for initial screening for Plasmodium infections, using published PCR reactions and protocols with minor modifications [8]. PCR-positive samples were subsequently tested using an additional method targeting the cytochrome B gene (cytb) designed for the current study. The primer sets for the hemi-nested cytb assay were as follows: PgCytbF1 (5′-GAATTATGGAGTGGATGGTG-3′) and PgCytbR1 (5′-ACATCCAATCCATAATAAAGC-3′) for nest 1 and PgCytbF1 and PgCytbR2 (5′-TTTTAACATTGCATAAAATGG-3′) for nest 2. Amplification cycling conditions were 95 °C for 3 min and then 30 cycles of 3 steps PCR, with 30 s annealing at 55 °C (nest 1) or 58 °C (nest 2) and elongation at 72 °C for 1 min. Nested products were then characterized by direct sequencing for species determination. Polymorphisms at the propeller domain of the Kelch 13 (K13) encoded by the P. falciparum k13 gene (PF3D7_1343700) were also determined on P. falciparum PCR-positive isolates, using previously described protocols for nested PCR methods and DNA sequencing [25].

Microscopic analysis

Thick and thin blood films were taken from each participant. Giemsa-stained thick malaria films were examined under a 100× oil-immersion lens. Samples were counted as negative if no parasite was seen after counting 400 white blood cells. Samples were counted as positive if one or more parasites were seen—the corresponding thin films were then examined with a 100× oil-immersion lens for speciation. All microscope slides were read in duplicate by technicians blinded to other reader’s findings.

Data analysis

Weighted prevalence of malaria species by PCR and serological status was estimated with 95% confidence intervals using the Stata survey commands (v14, Statacorp, Texas). To investigate transmission dynamics in the population, a simple reversible catalytic conversion model was fitted to the age-seroprevalence data using maximum likelihood methods as previously described [17]. The model fits age-seroprevalence curves and estimates seroconversion rate (SCR) as analogous to the force of infection. Profile likelihood plots were used to test for any step change in SCR and, if present, identify the most likely age at which this occurred [26]. Models with two SCRs instead of one were assumed if the likelihood ratio comparing models indicated a statistically significant change (p < 0.05). Univariate and multivariate logistic regression was used to investigate the relationship between gender, age, ethnicity, bed net ownership, SES, forest exposure, and seropositivity to P. falciparum antigens.

Results

A total of 701 houses in 27 clusters (villages) across 14 administrative wards were visited, of which 500 houses had at least one resident present. Of the 2112 recorded residents of consenting households, 474 (22.4%) were absent (Table 1). 1638 were present and all consented to take part in the study.
Table 1

Demographic characteristics of study participants

Study population
n%
Total1638100
Gender
 Males75245.9
 Female88654.1
Age
 0–51639.9
 6–1532419.8
 16–2525515.6
 26–5055033.6
 51–10034621.1
Ethnicity
 Burmese108664.1
 Indian50733.0
 Shan452.9
Socioeconomic status
 Lowest51332.4
 Middle54934.6
 Highest52333.0
Work in or visit forest
 Yes67141.0
 No96759.0
Household bed net ownership
 Yes, universal coverage39879.6
 No10220.4
Demographic characteristics of study participants The median age was 30 years (range 6 months-88 years) and 55% were female. 43% (57% of men and 27% of women) were classified as having had forest exposure (Table 1). 80% of households were classified as having universal bed net coverage, but very few households were reported as having been sprayed with insecticide in the past year (3%). The majority of participants were of Burmese origin (63%) whilst people of Indian origin represented 33% of the sample and Shan origin 3%. Absent household residents were more likely to be male and less likely to be Indian compared to those included in the study.

Malaria indicators

41 participants were found to have current infection when tested post hoc by PCR (2.6%, CI 1.5–4.3) (Table 2). The most common species detected was P. falciparum (1.1%, n = 19), followed by P. knowlesi (1.0%, n = 16). Plasmodium vivax (0.5%, n = 7) and Plasmodium malariae (0.08%, n = 1) (Fig. 2). Only two mixed infections were detected. Three infected individuals were febrile (one each of P. falciparum, P. knowlesi and P. vivax), the remaining 38 were afebrile (93%). No infected individuals reported any other malaria symptoms and none had sought treatment for malaria in the past three months. 89 febrile people were tested with an RDT and none were found positive, including three PCR-confirmed infections. P. falciparum and P. knowlesi infections were found in all age groups. Plasmodium knowlesi was most common between ages 5 and 15. Plasmodium vivax was only detected in those aged 15 and above.
Table 2

Prevalence of symptoms (fever) and specific Plasmodium species by PCR and serology

nPrevalence (95% CIs)Proportion of current infection (%)
Fever894.9 (3.5–7.1)3/89 (3.4%)
PCR
 Any Plasmodium species412.6 (1.5–4.3)100a
 P. falciparum 19(0.4–3.0)46.3 (28.7–59.1)
 P. knowlesi 16(0.5–2.2)39.0 (21.9–51.3)
 P. vivax 70.5 (0.1–2.0)17.1 (2.2–22.2)
 P. malariae 10.04 (0.0–0.4)2.4 (0–7.08)
Seropositive
 P. falciparum 1509.4 (6.0–15.0)
 P. vivax 503.1 (1.9–6.3)

aIncludes two mixed infections, one P. falciparum and P.vivax, one P. knowlesi and P. vivax, therefore total percentages may not equal 100%

Fig. 2

Proportion of Plasmodium species identified in a our sample and b WHO reporting for Myanmar. Pf, P. falciparum; Pv, P. vivax; Pk, P. knowlesi. K13 Pf samples with K13 mutations (not available for WHO statistics). * 1 × Pf Pv, 1 × Pk Pv, 1 × P. malariae

Prevalence of symptoms (fever) and specific Plasmodium species by PCR and serology aIncludes two mixed infections, one P. falciparum and P.vivax, one P. knowlesi and P. vivax, therefore total percentages may not equal 100% Proportion of Plasmodium species identified in a our sample and b WHO reporting for Myanmar. Pf, P. falciparum; Pv, P. vivax; Pk, P. knowlesi. K13 Pf samples with K13 mutations (not available for WHO statistics). * 1 × Pf Pv, 1 × Pk Pv, 1 × P. malariae 5 of the 19 (26.3%) P. falciparum samples harboured non-synonymous propeller domain mutations in pfk13 (K13). These included the known variant Val534Ala [27] and four novel variants: Arg539Val, Asn572Asp, Glu602Gly, and Glu620Gly. 9.4% (n = 150) individuals were seropositive to P. falciparum antigens whilst 3.1% (n = 50) were seropositive to P. vivax antigens. Of the 50, 19 (38%) were also positive to P. falciparum, indicating exposure to both species. Seropositivity to both P. falciparum and P. vivax was higher in men than women for both species (p value = 0.018 and 0.063 respectively). Microscope slide positivity had high inter-observer variability, in part due to water damage and fungal contamination of slides, and the microscopy results were therefore not included in the analysis.

Risk factors for exposure to malaria

Analysis of risk factors for malaria was restricted to seropositivity to P. falciparum due to the low numbers of infections detected by PCR. After adjusting for all other variables, seropositivity was more likely for men, [adjusted OR (AOR) 2.1 (1.3–3.4), p = 0.006], and less likely for those with higher SES [AOR 0.6 (0.3–0.9), p = 0.072], and of Indian origin [AOR 0.3 (0.1–0.8)]. There was a strong association between seropositivity and forest exposure in the unadjusted model, which was lost after adjusting for gender, age, ethnicity and SES (Table 3). Migration status (moving to Phyu within the last 10 years or visiting outside Phyu in the preceding 3 months) was not associated with an increased risk of malaria exposure in either the crude or adjusted analysis.
Table 3

Association between demographic and behavioural characteristics and exposure to P. falciparum in study participants

Sero-positive (%)Odds ratio (OR)p valueAdjusted ORa p valueDenominators
Un-weightedWeighted
Gender
 Female7.11.0 (baseline)1.0862871
 Male12.61.9 (1.3–2.8)0.0042.1 (1.3–3.4)0.006740731
Age
 0–5 years0.31.01.0162181
 5–15 years3.19.0 (1.4–58.9)9.0 (1.3–64.8)311292
 15–25 years3.811.2 (1.6–81.5)12.0 (1.5–94.8)253265
 25–50 years13.042.7 (4.0–456.3)43.8 (3.8–506.3)541544
 50–100 years20.071.2 (6.4–796.3)0.01471.3 (5.6–904.2)0.030335319
Working in/visiting forests
 No5.81.01.014541454
 Yes14.72.8 (1.5–5.1)0.0021.0 (0.6–1.8)0.9793131
Bed net ownership
 Not universal coverage6.61.01.0391417
 Universal coverage11.01.8 (0.8–3.8)0.1341.1 (0.5–2.5)0.76011611145
Socio-economic status
 Low11.61.01.0506462
 Medium11.20.9 (0.6–1.5)0.9 (0.6–1.6)532531
 Highest7.20.6 (0.4–0.9)0.0350.6 (0.3–0.9)0.072512566

aAdjusted for: age, gender, forest exposure, ethnicity, bed net ownership and socio-economic status

Association between demographic and behavioural characteristics and exposure to P. falciparum in study participants aAdjusted for: age, gender, forest exposure, ethnicity, bed net ownership and socio-economic status

Serological estimates of malaria transmission

A reversible catalytic model and profile likelihood plots were used to investigate whether there was evidence for two SCRs, indicative of two discrete levels of exposure within the population. For P. falciparum, there was a clear peak in profile likelihood plot at age 23 years, indicating a change in SCR (Fig. 3a). A model allowing for two SCRs fitted the data significantly better than a model with a single SCR (p = 0.016) (Fig. 3b).
Fig. 3

a Profile likelihood plot investigating the most likely age at which a change in seroconversion rate (SCR) occurs in P. falciparum serological data and b Seroprevalence curve fitted to P. falciparum with a change in SCR at age 23

a Profile likelihood plot investigating the most likely age at which a change in seroconversion rate (SCR) occurs in P. falciparum serological data and b Seroprevalence curve fitted to P. falciparum with a change in SCR at age 23 When analysed separately by gender, a model with two SCRs fitted better for men (p = 0.004) whilst a single SCR fit better for women (p = 0.548) (Fig. 4). The SCR in men over the age of 23 was 0.050 (0.010–0.251) compared to 0.003 (0.001–0.006) in those under 23 years old. In women, the SCR was similar to that of men under 23 [0.003 (0.001–0.005)].
Fig. 4

Seroprevalence curves for P. falciparum a males and b females. The data for males has been fitted with two serconversion rates (SCR), with a change at age 23, and the data for females has been fitted with a constant SCR

Seroprevalence curves for P. falciparum a males and b females. The data for males has been fitted with two serconversion rates (SCR), with a change at age 23, and the data for females has been fitted with a constant SCR Seropositivity to P. vivax antigens was low and SCR was also low [0.002 (0.0009–0.006)], with no evidence for a change in SCR.

Discussion

This household study reveals low-level malaria transmission among the general population in central Myanmar. The WHO estimates that P. falciparum causes 75% of clinical malaria in Myanmar and P. vivax 25% [28], whilst in this study P. falciparum mono-infection comprised 45% of infections and P. vivax 12% (Fig. 2). This study found P. knowlesi [29] in more than 35% of positive samples. Clinical diagnosis of malaria and most epidemiological studies in Myanmar use microscopy or RDT positivity to identify infection and both RDT and microscopy have poor sensitivity and specificity for P. knowlesi [30, 31]. In this study, reliable microscopy also proved technically challenging. This may explain the underrepresentation of P. knowlesi in national statistics and population-level data when compared to the findings presented here. In Malaysia, P. knowlesi is responsible for a similar proportion of cases as found in this study and can cause fatal illness [32]. The epidemiology of P. knowlesi in Myanmar requires further study, utilizing sensitive diagnostic tools. One quarter of P. falciparum samples harboured K13 mutations, all from afebrile, asymptomatic participants, none of whom reported anti-malarial treatment within the previous three months and none were followed up—it is therefore difficult to comment on the importance of these alleles as determinants of artemisinin susceptibility. Of the five K13 mutations detected, four have never previously been reported. One of the novel mutations, Arg539Val, is similar to previously described variants at codon 539 from Cambodia, Laos and Myanmar, though these all encode threonine rather than valine as the variant amino acid [27]. K13 mutations have recently been mapped in convenience samples in Myanmar and appear prevalent in Upper Myanmar and eastern border areas; no K13 mutations were found in a clinical cohort of 52 patients in Bago Region in 2013–2014 [33], although the prevalence of K13 mutations amongst clinical cohorts in the high-risk township of Shwe Kyin, Bago, was similar to that found in our population [5]. Most participants (n = 38; 93%) with current infection were afebrile and none reported symptoms. The three individuals with raised temperatures tested negative on RDT, possibly signifying a low-density parasitaemia (or alternative diagnoses) which may be associated with mild clinical symptoms [34]. However, even sub-clinical infections are important during elimination campaigns [35]; accurate identification and treatment of asymptomatic carriers—who might transmit infections and will tend not to seek treatment—proved crucial to eliminate malaria in a similar low-endemic setting [36]. The serological data support the PCR data and suggest that there has been ongoing low-level transmission of P. falciparum and P. vivax in the general population in Bago region. There was a notable increase in exposure to infection in men aged over 23, who experience a SCR 16-fold higher than the general population. Because the antibodies detected by these methods persist for an unknown period of time, there are two explanations indistinguishable by serology alone: malaria epidemiology may have changed 23 years ago such that men now aged over 23 were historically exposed to more malaria, or there may be ongoing behavioural risk factors specific to those aged over 23. The best working hypothesis is that the change in SCR is behavioural; it is confined to a well-defined epidemiological group (men of working age) and this population is overrepresented in contemporary clinic-based studies suggesting they remain at increased risk of malaria [16]. Forest work is an established risk factor for malaria transmission [37]. Plasmodium knowlesi is particularly associated with forest malaria, due to the outdoor biting habits of P. knowlesi vectors and the natural primate reservoirs living in forests [38]. The questionnaire captured self-reported information relating to occupational exposure and forest visits. Individuals reporting forest exposure were three times more likely to have evidence of previous exposure to malaria in the unadjusted analysis. However, forest workers were significantly more likely to be men and aged over 23 and less likely to be Indian. After adjusting for other factors including age, ethnicity and SES the association with forest exposure was no longer significant, which is consistent with forest exposure being on the causal pathway (although it cannot be excluded that it is a confounder). Illicit forest-related activities such as illegal logging are often unreliably reported in surveys, and qualitative studies may be needed to obtain more information on the spectrum of forest exposure as a risk behaviour for malaria in this region. The Myanmar Ministry of Health offers malaria prevention, diagnosis and treatment to the general population without distinction. This approach is reflected in the high level of bed-net ownership and might contribute to the low levels of transmission observed. However, these data suggest that a strategy tailored to those at highest risk and with asymptomatic infection might be required to eliminate malaria since bed-nets will not protect those working in forest plantations at dawn and dusk [14]. Targeted interventions have been trialed in other areas with varying degrees of success, including: insecticide-treated clothing and hammocks (for use in the forest); toxic mosquito baits; and personal insect-repellents [39]. Targeted mass administration of anti-malarials to specific demographic groups is another option [40]. As yet, none have been evaluated in Myanmar. This is the first study in Myanmar to combine detailed population-level epidemiological data with highly sensitive molecular techniques. The strength and novelty of this study also lie in the size of this probability sample from an important but unstudied population, with generalizability to Bago Region and central Myanmar. However, higher diagnostic sensitivity has been achieved with the technique of high volume ultra-sensitive qPCR [16] though this requires collection of larger blood volumes by venepuncture, and an unbroken cold-chain for transport of packed red cells to a specialist molecular biology laboratory. Point prevalence of current infection is sensitive to seasonal variation, and this study was conducted towards the end of the rains—regarded as the malaria high season—to sample at the peak of malaria transmission (though different seasonal peaks have been reported for some areas nearby [41, 42]). Moreover, others report little by way of seasonal variation [43], and by correlating PCR findings with serology, which is less sensitive to seasonal changes, robust hypotheses can be developed. The study aimed to minimize bias in this population-based study by weighting the sample so that it was broadly representative of national demographic data in Myanmar in terms of gender and age [44], but the sampling strategy excluded the population living closest to the flooded Sittang River due to adverse weather conditions, which made these areas inaccessible, and where malaria transmission might be higher. In addition, the ethnic composition of this sample differs from national averages because ethnicity in Myanmar is clustered [44]; the sample over-represented Indian participants (33% compared to 2% in national statistics) and underrepresented Shan (3% compared to 9%). One-fifth of residents were absent during study visits, and these individuals were more likely to be male and less likely to be of Indian origin, and this household survey did not include hospital in-patients being treated for malaria. We were only able to provide population weighting at the ward level due to a lack of available population statistics for individual villages. In our experience, village sizes did vary, though it is unlike that this would have affected our prevalence estimates, given the ward-level weighting applied and the small number of infections detected. The overall effect of our diagnostic techniques and sampling strategy is that the study design might have underestimated rather than overestimated malaria prevalence.

Conclusion

Malaria transmission in this area was low. However, there were low numbers of asymptomatic carriers who probably play an important role in maintaining local transmission, and many were infected with P. knowlesi. A higher proportion of K13 mutations among P. falciparum cases were observed than has previously documented in this region, and working age men appear at significantly higher risk of malaria exposure when compared to the general population, which needs further research. However, the public health implications are clear; the WHO goal of malaria elimination in this region will require identification and treatment of asymptomatic carriers among high-risk populations in order to control artemisinin resistance and successfully eliminate malaria in this setting.
  38 in total

1.  Evidence of artemisinin-resistant malaria in western Cambodia.

Authors:  Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

2.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Authors:  Frédéric Ariey; Benoit Witkowski; Chanaki Amaratunga; Johann Beghain; Anne-Claire Langlois; Nimol Khim; Saorin Kim; Valentine Duru; Christiane Bouchier; Laurence Ma; Pharath Lim; Rithea Leang; Socheat Duong; Sokunthea Sreng; Seila Suon; Char Meng Chuor; Denis Mey Bout; Sandie Ménard; William O Rogers; Blaise Genton; Thierry Fandeur; Olivo Miotto; Pascal Ringwald; Jacques Le Bras; Antoine Berry; Jean-Christophe Barale; Rick M Fairhurst; Françoise Benoit-Vical; Odile Mercereau-Puijalon; Didier Ménard
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

3.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

4.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.

Authors:  C V Plowe; A Djimde; M Bouare; O Doumbo; T E Wellems
Journal:  Am J Trop Med Hyg       Date:  1995-06       Impact factor: 2.345

5.  Spread of artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Elizabeth A Ashley; Mehul Dhorda; Rick M Fairhurst; Chanaki Amaratunga; Parath Lim; Seila Suon; Sokunthea Sreng; Jennifer M Anderson; Sivanna Mao; Baramey Sam; Chantha Sopha; Char Meng Chuor; Chea Nguon; Siv Sovannaroth; Sasithon Pukrittayakamee; Podjanee Jittamala; Kesinee Chotivanich; Kitipumi Chutasmit; Chaiyaporn Suchatsoonthorn; Ratchadaporn Runcharoen; Tran Tinh Hien; Nguyen Thanh Thuy-Nhien; Ngo Viet Thanh; Nguyen Hoan Phu; Ye Htut; Kay-Thwe Han; Kyin Hla Aye; Olugbenga A Mokuolu; Rasaq R Olaosebikan; Olaleke O Folaranmi; Mayfong Mayxay; Maniphone Khanthavong; Bouasy Hongvanthong; Paul N Newton; Marie A Onyamboko; Caterina I Fanello; Antoinette K Tshefu; Neelima Mishra; Neena Valecha; Aung Pyae Phyo; Francois Nosten; Poravuth Yi; Rupam Tripura; Steffen Borrmann; Mahfudh Bashraheil; Judy Peshu; M Abul Faiz; Aniruddha Ghose; M Amir Hossain; Rasheda Samad; M Ridwanur Rahman; M Mahtabuddin Hasan; Akhterul Islam; Olivo Miotto; Roberto Amato; Bronwyn MacInnis; Jim Stalker; Dominic P Kwiatkowski; Zbynek Bozdech; Atthanee Jeeyapant; Phaik Yeong Cheah; Tharisara Sakulthaew; Jeremy Chalk; Benjamas Intharabut; Kamolrat Silamut; Sue J Lee; Benchawan Vihokhern; Chanon Kunasol; Mallika Imwong; Joel Tarning; Walter J Taylor; Shunmay Yeung; Charles J Woodrow; Jennifer A Flegg; Debashish Das; Jeffery Smith; Meera Venkatesan; Christopher V Plowe; Kasia Stepniewska; Philippe J Guerin; Arjen M Dondorp; Nicholas P Day; Nicholas J White
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

6.  Rapid assessment of malaria transmission using age-specific sero-conversion rates.

Authors:  Laveta Stewart; Roly Gosling; Jamie Griffin; Samwel Gesase; Joseph Campo; Ramadan Hashim; Paul Masika; Jacklin Mosha; Teun Bousema; Seif Shekalaghe; Jackie Cook; Patrick Corran; Azra Ghani; Eleanor M Riley; Chris Drakeley
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

7.  Elimination of Plasmodium falciparum in an area of multi-drug resistance.

Authors:  Khin Maung Lwin; Mallika Imwong; Preyanan Suangkanarat; Atthanee Jeeyapant; Benchawan Vihokhern; Klanarong Wongsaen; Georges Snounou; Lilly Keereecharoen; Nicholas J White; Francois Nosten
Journal:  Malar J       Date:  2015-08-16       Impact factor: 2.979

8.  Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections.

Authors:  Kim-Sung Lee; Janet Cox-Singh; Balbir Singh
Journal:  Malar J       Date:  2009-04-21       Impact factor: 2.979

9.  Prevalence of Plasmodium falciparum in active conflict areas of eastern Burma: a summary of cross-sectional data.

Authors:  Adam K Richards; Linda Smith; Luke C Mullany; Catherine I Lee; Emily Whichard; Kristin Banek; Mahn Mahn; Eh Kalu Shwe Oo; Thomas J Lee
Journal:  Confl Health       Date:  2007-09-05       Impact factor: 2.723

10.  Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand.

Authors:  Waraphon Phimpraphi; Richard E Paul; Surapon Yimsamran; Supalarp Puangsa-art; Nipon Thanyavanich; Wanchai Maneeboonyang; Sutthiporn Prommongkol; Samarn Sornklom; Wutthichai Chaimungkun; Irwin F Chavez; Herve Blanc; Sornchai Looareesuwan; Anavaj Sakuntabhai; Pratap Singhasivanon
Journal:  Malar J       Date:  2008-06-02       Impact factor: 2.979

View more
  25 in total

Review 1.  Non-Human Primate Malaria Infections: A Review on the Epidemiology in Malaysia.

Authors:  Nor Diyana Dian; Mohd Amirul Fitri A Rahim; Sherwin Chan; Zulkarnain Md Idris
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

2.  Plasmodium knowlesi detection methods for human infections-Diagnosis and surveillance.

Authors:  Matthew J Grigg; Inke N Lubis; Kevin K A Tetteh; Bridget E Barber; Timothy William; Giri S Rajahram; Angelica F Tan; Colin J Sutherland; Rintis Noviyanti; Chris J Drakeley; Sumudu Britton; Nicholas M Anstey
Journal:  Adv Parasitol       Date:  2021-09-17       Impact factor: 3.125

3.  Knowlesi malaria: Human risk factors, clinical spectrum, and pathophysiology.

Authors:  Nicholas M Anstey; Matthew J Grigg; Giri S Rajahram; Daniel J Cooper; Timothy William; Steven Kho; Bridget E Barber
Journal:  Adv Parasitol       Date:  2021-08-28       Impact factor: 3.125

Review 4.  Global trend of Plasmodium malariae and Plasmodium ovale spp. malaria infections in the last two decades (2000-2020): a systematic review and meta-analysis.

Authors:  Joseph Hawadak; Rodrigue Roman Dongang Nana; Vineeta Singh
Journal:  Parasit Vectors       Date:  2021-06-03       Impact factor: 3.876

5.  Perspectives of health and community stakeholders on community-delivered models of malaria elimination in Lao People's Democratic Republic: A qualitative study.

Authors:  May Chan Oo; Khampheng Phongluxa; Win Han Oo; Sengchanh Kounnavong; Syda Xayyavong; Chanthaly Louangphaxay; Win Htike; Julia C Cutts; Kaung Myat Thu; Galau Naw Hkawng; Freya J I Fowkes
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

6.  Contribution of Plasmodium knowlesi to Multispecies Human Malaria Infections in North Sumatera, Indonesia.

Authors:  Inke N D Lubis; Hendri Wijaya; Munar Lubis; Chairuddin P Lubis; Paul C S Divis; Khalid B Beshir; Colin J Sutherland
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

7.  Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar.

Authors:  Myo Thiha Zaw; Myo Thant; Tin Maung Hlaing; Naing Zin Aung; Min Thu; Kanit Phumchuea; Kanokwan Phusri; Teerawat Saeseu; Ritthideach Yorsaeng; Wang Nguitragool; Ingrid Felger; Jaranit Kaewkungwal; Liwang Cui; Jetsumon Sattabongkot
Journal:  Malar J       Date:  2017-04-04       Impact factor: 2.979

8.  Community-based molecular and serological surveillance of subclinical malaria in Myanmar.

Authors:  Katherine O'Flaherty; Win Han Oo; Sophie G Zaloumis; Julia C Cutts; Kyaw Zayar Aung; Myat Mon Thein; Damien R Drew; Zahra Razook; Alyssa E Barry; Naanki Parischa; Nyi Nyi Zaw; Htin Kyaw Thu; Aung Thi; Wai Yan Min Htay; Aung Paing Soe; Julie A Simpson; James G Beeson; Paul A Agius; Freya J I Fowkes
Journal:  BMC Med       Date:  2021-05-28       Impact factor: 8.775

9.  Micro-epidemiology of malaria in an elimination setting in Central Vietnam.

Authors:  Melanie Bannister-Tyrrell; Nguyen Xuan Xa; Johanna Helena Kattenberg; Nguyen Van Van; Vu Khac Anh Dung; Truong Minh Hieu; Nguyen Van Hong; Eduard Rovira-Vallbona; Nguyen Thanh Thao; Tran Thanh Duong; Anna Rosanas-Urgell; Koen Peeters Grietens; Annette Erhart
Journal:  Malar J       Date:  2018-03-19       Impact factor: 2.979

10.  Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.

Authors:  Donelly A van Schalkwyk; Robert W Moon; Benjamin Blasco; Colin J Sutherland
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.